NASDAQ$QSI

Quantum-Si Inc · Q3 2022 earnings

Q3 2022 earnings · · Investor relations

Briefing

Quantum-Si reported financial results for the third quarter ending September 30, 2022.

Quantum-Si's net loss was $31.7 million, and adjusted EBITDA was negative $22.9 million. The company is preparing to launch its Platinum instrument and expects to begin shipments in Q1 2023.

  • Jeff Hawkins was appointed as Chief Executive Officer and director to the Board.
  • A paper was published in Science on real-time dynamic single-molecule protein sequencing.
  • A subsidiary was formed to accelerate protein engineering and directed evolution programs.
  • The company expects to launch its PlatinumTM protein sequencing instrument and start taking orders before the end of 2022 and begin shipments in Q1 2023.

Headline financials

EPS (adj)

-$0.23

Previous: -$0.13-76.9%
Adjusted EBITDA

-$22.9M

Previous: -$17.5M-30.7%
Total Operating Expenses

$27.7M

Previous: $25.2M+9.9%
Capital Expenditures

$1.78M

Previous: $1.13M+58.1%
Free Cash Flow

-$23.6M

Previous: -$20.4M-15.8%
Net Income

-$31.7M

Previous: -$18.1M-75.3%
Operating Income

-$27.7M

Previous: -$25.2M-9.9%
Cash & Equivalents

$78.3M

Previous: $62.1M+26.0%
Total Assets

$418M

Previous: $510M-18.0%
Stock-Based Comp

$4.04M

Previous: $7.4M-45.3%

Revenue & EPS history

Quantum-Si · Revenue · Quarterly

$258K

Q1 2026-69.4%vs Q1 2025
Beat estimate in 2 of 12 quarters(17%)
ActualEstimate

Forward guidance

Quantum-Si expects to launch its PlatinumTM protein sequencing instrument and start taking orders before the end of 2022 and begin shipments in Q1 2023. The company expects operating expenses to grow 25-30% year-over-year in 2022.

Tailwinds

  • Launch Platinum instrument and start taking orders before the end of 2022
  • Begin shipments in Q1 2023
  • Increase efforts to manage costs
  • Improve efficiencies
  • Lowering operating expense guidance for a second consecutive time

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2022

Historical avgQ3 2022

-4.1%

Avg return

Earnings day

-4.3%

Avg return

5 days after

+1.5%

Avg return

30 days after

39%

9 / 23 earnings

Positive

+14.5%

Q3 2023

Best reaction

-39.5%

Q2 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-4.5%-8.3%+1.0%
Q4 2025-4.3%-2.3%-21.1%
Q3 2025-8.5%-12.2%-20.0%
Q1 2025+0.0%-0.3%+12.2%
Q4 2024+6.2%-0.8%-10.8%
Q3 2024-20.8%-26.6%+81.0%
Q2 2024-2.8%-4.8%+4.5%
Q1 2024-5.6%+1.7%-17.8%
Q4 2023+6.3%-7.5%+13.2%
Q3 2023+14.5%+29.0%+26.6%
Q2 2023-39.5%-34.8%-31.9%
Q1 2023-13.5%-15.3%-1.8%
Q4 2022-12.5%-26.4%-27.8%
Q3 2022+3.2%+26.8%-7.6%
Q2 2022-6.0%+9.7%-14.4%
Q1 2022-14.9%-9.1%+3.0%
Q4 2019+6.2%-3.8%+12.5%
Q4 2021+6.8%-9.5%+13.1%
Q3 2021+1.2%+1.4%-21.5%
Q2 2021+1.9%+4.4%+14.2%
Q2 2020+1.9%+4.4%+14.2%
Q1 2021-7.6%-18.7%+28.5%
Q4 2020-1.1%+5.0%-13.8%
Q3 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro